SUPPLEMENTARY METHODS
along with RNA size makers (e.g., Ambion Century and Decade markers, Life Technologies) by 5% (for mRNAs) and 20% (for the leader RNA), respectively, urea-PAGE, and detected by autoradiography (4, 40) . Molar amounts of 32 P-labeled transcripts synthesized under the standard conditions were estimated as described previously (40) . The wild-type L protein synthesized 21 ± 1 fmol leader RNA and 7.7 ± 0.9 fmol N mRNA (the mean ± standard deviation of three independent determinations).
For cap analyses ( Figure S1D ), in vitro transcription was carried out in 25-µl reaction mixtures including 100 µM [α-32 P]GTP (3.5 × 10 4 cpm/pmol), 1 mM each of the other three NTPs, 0.8 µg of N-RNA complex, 0.1 µg of P, and 0.2 µg of L (wild-type or mutant). 32 P-Labeled transcripts were purified and then digested with 0.5 units of nuclease P1 and 1 unit of calf intestine alkaline phosphatase (CIAP), as described (40). The digests were mixed with DEAE Sephacel (GE Healthcare) in the presence of 0.1 M triethylamine-bicarbonate buffer (pH 7.5). After washing the resin with the same buffer, 32 P-labeled cap structures were eluted from the resin with 1 M triethylamine-bicarbonate buffer, and analysed along with cap analogues by PEI-cellulose TLC (40).
For enzymatic sequencing of short transcripts ( Figure 2C-G For post-capping of transcripts with the VSV L protein ( Figure 2H and I), unlabelled transcripts were synthesized with 0.1 µg of the HR-RH mutant in 25-µl reaction mixtures, purified as described above, and dissolved in 10 µl of H 2 O. Two-microliter aliquots were incubated in 10 µl of the VSV capping reaction mixtures (40) with 0.25 µM [α-32 P]GDP (1.7 × 10 3 cpm/fmol) and 0.2 µg of the D714A L mutant (6) for 30°C for 2 h ( Figure 2H ). After the capping reaction, the reaction mixtures were incubated with 1 unit of CIAP at 37°C for 10 min. Cap-labelled RNAs were purified by phenol/chloroform extraction followed by ethanol precipitation, and analysed by 20% urea-PAGE (40).
Similarly, 4 µl of the sample was subjected to a 20-µl VSV capping reaction with 0.25 µM [α-32 P]GDP (4.3 × 10 3 cpm/fmol) and 0.4 µg of the D714A L mutant ( Figure 2I ). 32 P-Labeled RNAs were purified by 20% urea-PAGE, and their nuclease P1-digests were analysed by PEI-cellulose TLC (40).
For Northern blot analyses (Figures 3, 4 , 5A, and S3), unlabelled transcripts were synthesized with 0.1 µg of the wild-type or mutant L protein in 25-µl reaction mixtures as described above, and deadenylated with RNase H and oligo(dT) when indicated. RNAs were purified by phenol/chloroform extraction followed by ethanol precipitation, and dissolved in 10 µl of H 2 O. Small RNAs in 2.5-µl aliquots were separated by 15% urea-PAGE, transferred to Hybond NX nylon membranes (GE Healthcare), and crosslinked to the membranes with 1-ethyl-3-[3-dimethylaminopropyl)carbodiimide (Thermo Scientific) as described by Pall and Hamilton (41) . Long deadenylated RNAs in 2-µl aliquots were separated by 5% urea-PAGE, transferred to Immobilon NY+ membranes (Millipore), and UVcrosslinked, as described (40). When indicated, 20-fold diluted samples (corresponding to 0.1-µl aliquots) were analysed. Transcripts on the membranes were hybridized with 5′-end-32 P-labeled oligo-DNA probes complementary to the leader RNA or mRNAs (see Figure legends) , and visualized by autoradiography, as described (40).
For 5′-RACE analysis ( Figures 5B and S4 ), unlabelled transcripts were synthesized with 0.1 µg of the wild-type or HR-RH mutant L protein in 25-µl reaction mixtures as described above. One percent and twenty percent of the total volumes of the wild-type and HR-RH RNA samples, respectively, were subjected to 5′-RACE analyses (see Materials and Methods in the main text). 
Generation of recombinant VSVs
To construct plasmids encoding a full-length anti-genome with the wild-type or mutant L gene, the 5.7-kbp HpaI-HindIII region of the L gene in the pVSVFL-2 plasmid (46) was replaced with the corresponding HpaI-HindIII fragment derived from the pFastBac L-H plasmid encoding the wild-type or mutant L protein (6), or pBS-L(HR1-1) plasmid encoding the D1671V mutant L protein (8).
Although the resulting plasmid with the wild-type L gene (pVSV-L WT) has two nucleotide changes from the original sequence of pVSVFL-2, one of which leads to one amino acid change from proline at position 87 to serine in the L protein, there was no apparent difference in growth phenotypes between recombinant viruses generated from pVSVFL-2 and pVSV-L WT (data not shown). BHK-21 cells (2 × 10 6 cells) were infected with vTF7-3 (recombinant vaccinia virus expressing T7 RNA polymerase) at a multiplicity of infection of 1, transfected with pVSV-L WT or its mutant plasmid (2 µg) along with the supporting plasmids, pBS-N (0.4 µg), pBS-P (1.2 µg), and pBS-L (0.2 µg), using the FuGENE HD transfection reagent (Roche Applied Science), and cultured in DMEM supplemented with 5% FBS at 30°C for 4 days in a CO 2 incubator. The culture supernatants were filtrated through 0.22-µm syringe filters to remove vaccinia virus as described (46), and added to fresh BHK-21 cells (5 × 10 6 cells).
The cells were cultured at 30°C for 2 (for wild-type) or 3 (for other mutants) days. The culture supernatants were recovered and filtrated through 0.22-µm filters. To determine titers of recombinant viruses, 100-µl aliquots of the filtrates and their 10-fold serial dilutions were subjected to a standard plaque assay with CV-1 cells in 6-well culture plates. Plaques were developed under agarose overlays at 30°C for 4 days in a CO 2 incubator, and fixed cells were stained with crystal violet. were subjected to digestion with RNA 5′-triphosphatase (RTPase) of vaccinia virus capping enzyme or tobacco acid pyrophosphatase (TAP), as described previously (4). The resulting digests were analysed by PEI-cellulose TLC followed by autoradiography. Figure S3 . N 1 and N 2 RNAs synthesized by the HR-RH mutant have a 5′-tri-or di-phosphate group.
(A) Deadenylated RNAs, synthesized by either the wild-type (WT) or HR-RH mutant L protein (see Figure 4B , lanes 9 and 5), were analysed by Northern blotting with the 32 P-labeled (-)N401-428 probe.
(B) The same samples used in panel A were subjected to in vitro capping with vaccinia virus capping enzyme in the presence of [α-32 P]GTP. The resulting capped RNAs were analysed by 5% urea-PAGE followed by autoradiography. Figure S4 . The 5′-terminal sequences of 3′-polyadenylated N transcripts synthesized by the wild-type or HR-RH mutant L protein.
As described in Figure 5B N is any nucleotide; V is A, G, or C; W is U or A; H is C, U, or A; Y is C or U; B is G, C, or U; D is A, G, or U.
